The optimal use of granulocyte macrophage colony stimulating factor in radiation induced mucositis in head and neck squamous cell carcinoma

Journal of Cancer Research and Therapeutics

Volumn 1, Issue 3, 2005, Pages 136-141

  Nidhi, Patni ^a   Sanjeev, Patni ^a   Ajay, Bapna ^a  

^a Bhagwan Mahaveer Cancer Hospital   (India)

Author keywords

Acute toxicity; GM CSF; Head and neck carcinoma; Radiation mucositis

Indexed keywords

EID: 33645558774     PISSN: 09731482     EISSN: 09731482     Source Type: Journal    
DOI: 10.4103/0973-1482.19589     Document Type: Article

References (34)

1. Annual report 1998, Hospital Cancer Registry Tata Memorial Hospital, Mumbai, India.
2. Dinshaw KA, Pande SC, Sharma V. Principles of radiation therapy. In: Desai PB, editor. Head and Neck Cancer - A multidisciplinary approach for its control & cure - UICC special project. Bombay: Tata Press Ltd.; 1995. p. 115-24.
3. Baker DG. The radiological basis for tissue reactions in the oral cavity following therapeutic irradiation Arch. Otolaryngol, 1982;108:21-4.
4. Dazzi C. Prophylaxis with GM-CSF mouth washes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high dose chemotherapy with autologous peripheral blood stem cell transplantation rescue:a double blind, randomized, placebo-controlled study. Annals of Oncology 2003;14:559-63.
5. Cooper JS, Carcinomas of the oral cavity and oropharynx, Moss' Radiation Oncology - Rationale, Technique, Results 1994;169 -213.
6. Maciejewski B, Zajusz A, Pilecki B. Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer. Radiother. Oncol 1991;22:7-11.
7. Sonis ST. Management of oral mucositis. Cancer 2004; 100;1995-2025.
8. Sonis ST. Oral mucositis in Cancer Therapy. J Support Oncol 2004;2:3-8.
9. Bataini JP, Asselain B, Jaulerry C, Brunin F, Bernier J, Pontvert D, et al. A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of tonsillar region:Clinical and treatment parameters as prognostic factors. Radiother Oncol 1989;14:265-77.
10. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:437-67.
11. Withers HR, Jaylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-46.
12. Sonis ST, Peterson DE, Mc guire DB. Prevention of mucositis in cancer patients. J Natl cancer Inst Monogr 2001;29:1-2.
13. Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJ, et al. Granulocyte & Granulocyte macrophage colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989;337:471-3.
14. Mckay IA, Leigh IM. Epidermal cytokines and their roles in cutaneous wound healing. Br J Dermatol 1991;124:513-8.
15. Gabbiani G. Modulation of fibroblasts cytoskeletal features during wound healing and firbrosis. In: van Furth R, editor. Hematopoietic growth factors and mononuclear phagocytes Basel: S Karger 1993:211-5.
16. Gordon B, Spadinger A, Hodges E, Ruby E, Stanley R, Coccia P. Effect of granulocyte macrophage colony stimulating factor on oral mucositis after hematopoietic stem-cell transplantation. J Clin Oncol 1994;12:1917-22.
17. Schuchter LM, Luginbuhl WE, Meropol NJ. The current status of toxicity protectants in Cancer therapy. Semin Oncol 1992;19:742-51.
18. Zaghloul MS, Dorie MJ, Kallman RF. Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum and tumor. Int J Radiat Oncol Biol Phys 1993;26:417-25.
19. Zaghloul MS, Dorie MJ, Kallman RF. Interleukin -1 increases thymidine labeling index of normal tissues of mice but not the tumor. Int J Radiat Oncol Biol Phys 1994;29:805-11.
20. Kannan V, Poonamallee D Bapsy, Naranappa Anantha. Efficacy and safety of granulocyte macrophage colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma. Int J Radiat Oncol Biol Phys 1997;37:1005-10.
21. Hamilton JA. Colony stimulating factors, cytokines and monocyte macrophages some controversies. Immunol. Today 1993;14:18-24.
22. Foote RL, Loprinzi CL, Frank AR, O'Fallon JR, Gulavita S, Tewfik HH, et al. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation - induced mucositis. J Clin Oncol 1994;12:2630-3.
23. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head neck cancer receiving radiotherapy with or without chemotherapy. A systematic literature review. Radiother Oncol 2003;66:253-62.
24. Fu KK, Pajak TF, Trotti A. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compase hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas:first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
25. Al-Tikriti U, Martin MV, Bramley PA. A pilot study of the clinical effects of irradiation on the oral tissues. Br J Oral Maxillofac Surg 1984;2277-87.
26. Horiot JC, LeFur R, Guyjen NT. Hyperfractionation vs. connentional fractionation in oropharyngeal carcinoma. Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992;25:231-41.
27. Lieschke GJ, Burgess AW. Granulocyte Colony stimulating factor and granulocyte -macrophage. Colony stimulating factor. N Engl J Med 1992;327:28-35.
28. Fuks Z, Haimovitz-Friedman A, Kolesnick RN. The role of sphingomyelin pathway and protein kinase C in radiation induced cell kill. In: De vita VT, Hellman S, Rosenberg SA, editors. Important advances in oncology 1995. Philadelphia, PA: Lippincotts Co; 1995. p. 19-31.
29. Woloschak GE, Chang-Liu GM, Jones PS. Modulation of gew expression in murine and hamster embryo cells following ionising radiation. Cancer Res 1990;53:339-44.
30. Nicolatou O, Sotiropoulou-Lontou A, Skarlatos J, Kyprianou K, Kolitsi G, Dardoufas K. A pilot study of the effect of granulocyte-macrophage colony stimulating factor on oral mucositis in head and neck cancer patients during x-radiation therapy: a preliminary report. Int J Radiat Oncol Biol Phys 1998;42:551-6.
31. Makkonen TA, Minn H, Jekunen A. Granulocyte macrophage colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation induced mucositis: a prospective randomized study. Int J Radiat Oncol Biol Phys 2000;46:525-34.
32. Sprinzl GM, Galvan O, de Vries A. Local application of granulocyte - macrophage colony stimulation factor (GM-CSF) for the treatment of oral mucositis. Eur J Cancer 2001;37:2003-9.
33. Saarilahti K, Kajanti M, Joensuu T, Kouri M, Joensuu H. Comparison of granulocyte - macrophage colony-stimulating factor and surcralfate mouthwashes in the prevention of radiation induced mucositis:a double blind prospective randomized phase III study. Int J Radiat Oncol Biol Phys 2002;54:479-85.
34. Rovirosa A, Ferre J, Biete A. Granulocyte Macrophage-colony stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy. Int J Radiat Oncol Biol Phys 2001;50:1373-4.